1,760
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

TNF-α increases the expression and activity of vitamin D receptor in keratinocytes: role of c-Jun N-terminal kinase

, , &
Article: e1137399 | Received 21 Oct 2015, Accepted 28 Dec 2015, Published online: 25 Mar 2016

References

  • Levy J, Gassmuller J, Schroder G, Audring H, Sonnichsen N. Comparison of the effects of calcipotriol, prednicarbate, and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. Skin Pharmacol 1994; 7:231-6; PMID:8024805; http://dx.doi.org/10.1159/000211299
  • Van de Kerkhof PC. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br J Dermatol 1995; 132:675-82; PMID:7772470; http://dx.doi.org/10.1111/j.1365-2133.1995.tb00710.x
  • Lutzow-Holm C, De Angelis P, Clausen OP. Calcitriol and its analog KH 1060 induce similar changes in keratinocyte cell cycle progression after topical application to mouse skin. A bromodeoxyuridine pulse-chase flow cytometric study. J Invest Dermatol Symp Proc 1996; 1:54-9
  • Gniadecki R. Stimulation versus inhibition of keratinocyte growth by 1,25-dihydroxyvitamin D3: Dependence on cell culture conditions. J Invest Dermatol 1996; 106:510-6; PMID:8648185; http://dx.doi.org/10.1111/1523-1747.ep12343866
  • Bikle DD. Vitamin D: Role in skin and hair. In: Feldman D, Pike JW, Glorieux FH, editors. Vitamin D. 2nd edition. Boston, San Diego, London: Elsevier Academic Press 2005. p 609-30
  • Diker-Cohen T, Koren R, Ravid A. Programmed cell death of stressed keratinocytes and its inhibition by vitamin D: The role of death and survival signaling pathways. Apoptosis 2006; 11:519-34; PMID:16532377; http://dx.doi.org/10.1007/s10495-006-5115-1
  • Miodovnik M, Koren R, Ziv E, Ravid A. The inflammatory response of keratinocytes and its modulation by vitamin D: the role of MAPK signaling pathways. J Cell Physiol 2012; 227:2175-83; PMID:21792935; http://dx.doi.org/10.1002/jcp.22951
  • Lehmann B, Querings K, Reichrath J. Vitamin D and skin: New aspects for dermatology. Exp Dermatol 2004; 13(Suppl 4):11-5; PMID:15507106; http://dx.doi.org/10.1111/j.1600-0625.2004.00257.x
  • Albanesi C, Scarponi C, Giustizieri ML, Girolomoni G. Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 2005; 4:329-34; PMID:16101542; http://dx.doi.org/10.2174/1568010054022033
  • Bikle DD. Vitamin D regulated keratinocyte differentiation. J Cell Biochem 2004; 92:436-44; PMID:15156556; http://dx.doi.org/10.1002/jcb.20095
  • Schauber J, Dorschner RA, Cuda AB. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 2007; 117:803-11; PMID:17290304; http://dx.doi.org/10.1172/JCI30142
  • Ziv E, Rotem C, Miodovnik M, Ravid A, Koren R. Two modes of ERK activation by TNF in keratinocytes: Different cellular outcomes and bi-directional modulation by vitamin D. J Cell Biochem 2008; 104:606-19; PMID:18080320; http://dx.doi.org/10.1002/jcb.21650
  • Garach-Jehoshua O, Ravid A, Liberman UA, Koren R. 1,25-Dihydroxyvitamin D3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes. Endocrinology 1999; 140:713-21; PMID:9927298
  • Elder JT, Astrom A, Pettersson U, Tavakkol A, Christopher EMG, Krust A, Kastner P, Chambon P, Voorhes JJ. Differential regulation of retinoic acid receptors and binding proteins in human skin. J Invest Dermatol 1992; 98:673-9; PMID:1314862; http://dx.doi.org/10.1111/1523-1747.ep12499896
  • Costa EM, Hirst MA, Feldman D. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells. Endocrinol 1985; 117:2203-10; PMID:2995009; http://dx.doi.org/10.1210/endo-117-5-2203
  • Santiso-Mere D, Sone T, Hilliard GM 4th, Pike JW, McDonnell DP. Positive regulation of the vitamin D receptor by its cognate ligand in heterologous expression systems. Mol Endocrinol 1993; 7:833-9; PMID:8413308
  • Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Endocrinol Metab Clin North Am 2010; 39:255-69; PMID:20511050; http://dx.doi.org/10.1016/j.ecl.2010.02.007
  • Agrawal T, Gupta GK, Agrawal DK. Vitamin D deficiency decreases the expression of VDR and prohibitin in the lungs of mice with allergic airway inflammation. Exp Mol Pathol 2012; 93:74-81; PMID:22537547; http://dx.doi.org/10.1016/j.yexmp.2012.04.004
  • Xiong M, Gong J, Liu Y, Xiang R, Tan X. Loss of vitamin D receptor in chronic kidney disease: a potential mechanism linking inflammation to epithelial-to-mesenchymal transition. Am J Physiol Renal Physiol 2012; 303:F1107-15;PMID:22791341; http://dx.doi.org/10.1152/ajprenal.00151.2012
  • Gupta GK, Agrawal T, Del Core MG, Hunter WJ 3rd, Agrawal DK. Decreased expression of vitamin D receptors in neointimal lesions following coronary artery angioplasty in atherosclerotic swine. PLoS One 2012; 7:e42789; PMID:22880111; http://dx.doi.org/10.1371/journal.pone.0042789
  • Ravid A, Rubinstein E, Gamady A, Rotem C, Liberman UA, Koren R. Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes. J Endocrinol 2002; 173:525-32; PMID:12065242; http://dx.doi.org/10.1677/joe.0.1730525
  • Bahar-Shany K, Ravid A, Koren R. Upregulation of MMP-9 production by TNFalpha in keratinocytes and its attenuation by vitamin D. J Cell Physiol 2010; 222:729-37; PMID:20020446
  • Qi X, Pramanik R, Wang J, Schultz RM, Maitra RK, Han J, DeLuca HF, Chen G. The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D3-induced growth inhibition. J Biol Chem 2002; 277:25884-92; PMID:11983707; http://dx.doi.org/10.1074/jbc.M203039200
  • Li QP, Qi X, Pramanik R, Pohl NM, Loesch M, Chen G. Stress-induced c-Jun-dependent Vitamin D receptor (VDR) activation dissects the non-classical VDR pathway from the classical VDR activity. J Biol Chem 2007; 282:1544-51; PMID:17121851; http://dx.doi.org/10.1074/jbc.M604052200
  • Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. J Endocrinol 2005; 185:577-92; PMID:15930183; http://dx.doi.org/10.1677/joe.1.05770
  • Piguet PF, Grau GE, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 1991; 173:673-9; PMID:1900080; http://dx.doi.org/10.1084/jem.173.3.673
  • LaDuca JR, Gaspari AA. Targeting tumor necrosis factor α. New drugs used to modulate inflammatory diseases. Dermatol Clin 2001; 19:617-35; PMID:11705350; http://dx.doi.org/10.1016/S0733-8635(05)70304-1
  • Trent JT, Kerdel FA. Tumor necrosis factor α inhibitors for the treatment of dermatologic diseases. Dermatol Nurs 2005; 17:97-107; PMID:15916184
  • Reichrath J. Vitamin D and the skin: An ancient friend, revisited. Exp Dermatol 2007; 16:618-25; PMID:17576242; http://dx.doi.org/10.1111/j.1600-0625.2007.00570.x
  • Schauber J, Gallo RL. The vitamin D pathway: A new target for control of the skin's immune response? Exp Dermatol 2008; 17:633-9; PMID:18573153; http://dx.doi.org/10.1111/j.1600-0625.2008.00768.x